GTBPGT Biopharma, Inc.vs its industry peers
A metric-by-metric comparison of GT Biopharma, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GTBP본 종목 | $239M#5 | 1.0x#1 | 67.0x#9 | — | — | -115.4%#9 | — | -794.5%#10 | — | — | -66.3%#3 | 0.1%#2 |
| BCYC | — | — | — | — | 105.8%#3 | -29.5%#3 | -340.4%#5 | -43.3%#5 | -372.9%#5 | — | -55.4%#2 | — |
| CAMP | $251M#1 | — | — | 71.8x#8 | 436.5%#1 | -55.2%#6 | -1502.4%#7 | — | — | — | — | — |
| LRMR | $245M#2 | — | 1.9x#7 | — | — | -105.5%#8 | — | -130.1%#9 | -350.3%#4 | — | -39.5%#1 | — |
| LFCR | $243M#3 | — | — | 1.9x#3 | 0.5%#7 | -422.5%#11 | -13.4%#3 | — | -28.7%#1 | 3#2 | — | — |
| ABEO | $240M#4 | — | 1.9x#6 | 41.3x#7 | — | -211.7%#10 | -1536.9%#8 | -55.6%#6 | -121.6%#2 | — | — | — |
| VNDA | $227M#6 | — | 1.1x#3 | 1.0x#2 | 8.7%#5 | -1066.7%#12 | -70.0%#4 | -110.3%#7 | — | — | — | — |
| EVMN | $225M#7 | 1.1x#2 | 0.8x#1 | 17.3x#5 | 85.7%#4 | -3.1%#2 | -623.6%#6 | -24.8%#3 | — | — | -68.7%#4 | — |
| NATR | $216M#8 | 12.3x#3 | 1.6x#5 | 0.5x#1 | 5.7%#6 | 153.7%#1 | 5.2%#2 | 14.3%#1 | — | 9#1 | — | — |
| CTNM | $211M#9 | — | 0.9x#2 | — | -100.0%#9 | -41.9%#5 | — | -25.0%#4 | — | — | — | — |
| SIGA | $210M#10 | — | 1.3x#4 | 2.2x#4 | -31.8%#8 | -60.7%#7 | 25.1%#1 | 14.1%#2 | — | — | — | 20.5%#1 |
| KRRO | $209M#11 | — | 2.0x#8 | 32.7x#6 | 181.5%#2 | -40.3%#4 | -1906.4%#9 | -113.6%#8 | -155.2%#3 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice